“…A recent study indicated that treatment of cancer cells with demethylation drugs results in increased invasive and metastatic phenotypes via the restoration of the expression of certain oncogenes, such as TGFb, ROS, and MMP (Shukeir et al, 2006;Ateeq et al, 2008;Cui et al, 2008;Jun et al, 2009). A recent study indicated that miR-196a-2 might have a potentially oncogenic role in breast tumorigenesis and hypermethylation of a CpG island upstream of the miR-196a-2 precursor was also associated with reduced breast cancer risk (Hoffman et al, 2009).…”